Free Trial
NASDAQ:VTRS

Viatris (VTRS) Stock Price, News & Analysis

Viatris logo
$9.80 -0.09 (-0.96%)
As of 01:14 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Viatris Stock (NASDAQ:VTRS)

Advanced

Key Stats

Today's Range
$9.72
$9.92
50-Day Range
$8.74
$10.69
52-Week Range
$6.85
$13.55
Volume
3.23 million shs
Average Volume
12.62 million shs
Market Capitalization
$11.44 billion
P/E Ratio
N/A
Dividend Yield
4.89%
Price Target
$10.40
Consensus Rating
Reduce

Company Overview

Viatris Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
23rd Percentile Overall Score

VTRS MarketRank™: 

Viatris scored higher than 23% of companies evaluated by MarketBeat, and ranked 838th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Viatris has received a consensus rating of Reduce. The company's average rating score is 1.80, and is based on 1 buy rating, 2 hold ratings, and 2 sell ratings.

  • Upside/Downside

    The consensus price target for Viatris is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    Viatris has received no research coverage in the past 90 days.

  • Read more about Viatris' stock forecast and price target.
  • Earnings Growth

    Earnings for Viatris are expected to decrease by -4.10% in the coming year, from $2.68 to $2.57 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Viatris is -3.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Viatris is -3.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Viatris has a P/B Ratio of 0.63. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Viatris' valuation and earnings.
  • Percentage of Shares Shorted

    3.56% of the float of Viatris has been sold short.
  • Short Interest Ratio / Days to Cover

    Viatris has a short interest ratio ("days to cover") of 4.3.
  • Change versus previous month

    Short interest in Viatris has recently increased by 9.13%, indicating that investor sentiment is decreasing significantly.
  • Dividend Leadership

    Viatris is a leading dividend payer. It pays a dividend yield of 4.87%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    Viatris does not have a long track record of dividend growth.

  • Dividend Sustainability

    Based on earnings estimates, Viatris will have a dividend payout ratio of 18.68% next year. This indicates that Viatris will be able to sustain or increase its dividend.

  • Read more about Viatris' dividend.
  • Percentage of Shares Shorted

    3.56% of the float of Viatris has been sold short.
  • Short Interest Ratio / Days to Cover

    Viatris has a short interest ratio ("days to cover") of 4.3.
  • Change versus previous month

    Short interest in Viatris has recently increased by 9.13%, indicating that investor sentiment is decreasing significantly.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Viatris this week, compared to 11 articles on an average week.
  • Search Interest

    Only 10 people have searched for VTRS on MarketBeat in the last 30 days. This is a decrease of -57% compared to the previous 30 days.
  • MarketBeat Follows

    9 people have added Viatris to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Viatris insiders have bought 204.92% more of their company's stock than they have sold. Specifically, they have bought $219,780.00 in company stock and sold $72,078.00 in company stock.

  • Percentage Held by Insiders

    Only 0.13% of the stock of Viatris is held by insiders.

  • Percentage Held by Institutions

    79.88% of the stock of Viatris is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Viatris' insider trading history.
Receive VTRS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Viatris and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VTRS Stock News Headlines

Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why
Imagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA or Bitcoin, but by owning a simple index fund. It sounds impossible. Yet it happened – just a short time ago. Now a legendary figure says: "Brace yourselves. It's about to happen here, in America. But fair warning – it could be the worst thing that ever happens to you." This story has received little coverage in the press. But if history repeats, it could bump tens of millions of Americans into a 7-figure net worth practically overnight.tc pixel
Viatris rises after a steep seven-day slide
1 Volatile Stock on Our Buy List and 2 Facing Challenges
See More Headlines

VTRS Stock Analysis - Frequently Asked Questions

Viatris' stock was trading at $12.45 at the start of the year. Since then, VTRS stock has decreased by 21.0% and is now trading at $9.8360.

Viatris Inc. (NASDAQ:VTRS) announced its quarterly earnings data on Thursday, August, 7th. The company reported $0.62 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.56 by $0.06. The business's quarterly revenue was down 5.6% compared to the same quarter last year.
Read the conference call transcript
.

Viatris' Board of Directors initiated a share repurchase plan on Wednesday, February 28th 2024, which permits the company to repurchase $1,000,000,000 in outstanding shares, according to EventVestor. This means that the company could reacquire up to 6.7% of its stock through open market purchases. Stock buyback plans are typically an indication that the company's board believes its shares are undervalued.

Viatris' top institutional investors include Vanguard Group Inc. (12.36%), Davis Selected Advisers (5.66%), State Street Corp (4.74%) and Geode Capital Management LLC (2.66%). Insiders that own company stock include Rajiv Malik, Scott Andrew Smith, Anthony Mauro, Paul Campbell, Harry Korman, Brian Roman, Xiangyang (Sean) Ni, Dillon Joellen Lyons, Goff Corinne Le and Andrew Cuneo.
View institutional ownership trends
.

Shares of VTRS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Viatris investors own include Pfizer (PFE), NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Intel (INTC), Tesla (TSLA) and Walt Disney (DIS).

Company Calendar

Last Earnings
8/07/2025
Record date for 9/15 Dividend
8/22/2025
Ex-Dividend for 9/15 Dividend
8/22/2025
Dividend Payable
9/15/2025
Today
9/22/2025
Next Earnings (Estimated)
11/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:VTRS
CIK
1792044
Employees
32,000
Year Founded
2020

Price Target and Rating

High Price Target
$13.00
Low Price Target
$9.00
Potential Upside/Downside
+5.1%
Consensus Rating
Reduce
Rating Score (0-4)
1.80
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.90)
Trailing P/E Ratio
N/A
Forward P/E Ratio
3.69
P/E Growth
N/A
Net Income
-$634.20 million
Net Margins
-24.57%
Pretax Margin
-26.57%
Return on Equity
16.54%
Return on Assets
7.06%

Debt

Debt-to-Equity Ratio
0.94
Current Ratio
1.37
Quick Ratio
0.77

Sales & Book Value

Annual Sales
$14.12 billion
Price / Sales
0.82
Cash Flow
$5.10 per share
Price / Cash Flow
1.94
Book Value
$15.61 per share
Price / Book
0.63

Miscellaneous

Outstanding Shares
1,165,872,000
Free Float
1,164,356,000
Market Cap
$11.54 billion
Optionable
Optionable
Beta
0.93

Social Links

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:VTRS) was last updated on 9/22/2025 by MarketBeat.com Staff
From Our Partners